Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial

Ocvirk, Janja; Brodowicz, Thomas; Wrba, Fritz; Ciuleanu, Tudor; Kurteva, Galina; Beslija, Semir; Koza, Ivan; Zsuzsanna Papai, Zsuzsanna; Messinger, Diethelm; Yilmaz, Ugur; Zsolt Faluhelyi, Zsolt; YALÇIN, ŞUAYİB; Papamichael, Demetris; Miklos Wenczl, Miklos; Mrsic-Krmpotic, Zrinka; Shacham-Shmueli, Einat; Vrbanec, Damir; Esser, Regina; Scheithauer, Werner; Zielinski, Christoph

doi:10.3748/wjg.v16.i25.3133

Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial

Ocvirk J., Brodowicz T., Wrba F., Ciuleanu T. E., Kurteva G., Beslija S., ...Daha Fazla

WORLD JOURNAL OF GASTROENTEROLOGY, cilt.16, sa.25, ss.3133-3143, 2010 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 16 Sayı: 25
Basım Tarihi: 2010
Doi Numarası: 10.3748/wjg.v16.i25.3133
Dergi Adı: WORLD JOURNAL OF GASTROENTEROLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.3133-3143
Hacettepe Üniversitesi Adresli: Evet

Özet

AIM: To investigate efficacy and safety of cetuximab combined with two chemotherapy regimens in patients with unresectable metastatic colorectal cancer (mCRC).